Literature DB >> 20422823

Usefulness of laboratory data in estimation of Crohn's disease activity.

Nadza Zubcevic1, Rusmir Mesihovic, Smail Zubcevic.   

Abstract

Crohn's disease (CD) is a chronic inflammatory disease characterized by unpredictable and severe course. Most clinicians use simple laboratory parameters of inflammatory activity such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), the number of leukocytes (Le) and platelet count to assess disease activity. The aim of this paper was to determine the value of various laboratory parameters in the assessment of Crohn's disease activity. The study included 36 patients, 15 men and 21 women, treated for Crohn's disease at the Gastroenterohepatology Clinic, Clinical Centre, University of Sarajevo, in period 2006 and 2007. Assessed patients were divided into three groups, according to the degree of disease activity, which was determined using the Crohn's Disease Activity Index (CDAI). Mild disease (MD) was present in 15, moderately severe disease (MSD) in 14, and severe disease (SD) in 7 patients. Statistical significance of association between values of laboratory parameters with the degree of severity of illness was investigated using the 95% Confidence Interval test. CRP showed a statistical significance for the relationship between MD-MSD (95% CI 6,645-74,333) and the relationship between MD-SD (95% CI 4,114-135,278), while the relationship between MSD-SD was not statistically significant. MPV showed statistical significance only for the relationship between MD-MSD (95% CI 0,060-2,909). Sedimentation rate and the number of red blood cells showed statistical significance for the relationship MD-SD (95% CI 10,638-62,943 and 0,077-1,080). Haemoglobin, hematocrit and platelet count showed statistical significance for the relationship between MD-MSD and MD-SD. Number of leukocytes did not show any statistically significant relationship with clinical activity of disease. The most reliable indicators of activity of Crohn's disease in this study were CRP, MPV, haemoglobin, hematocrit and platelet count, while leukocyte number did not correlate with disease activity. Neither parameter was sensitive enough to distinguish the relationship between moderately severe disease and severe disease. Until finding a "gold standard" for assessment of clinical disease activity, various laboratory and other parameters must be combined and compared with other indicators, such as endoscopic findings and radiological results.

Entities:  

Mesh:

Year:  2010        PMID: 20422823

Source DB:  PubMed          Journal:  Med Arh        ISSN: 0350-199X


  8 in total

1.  Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever.

Authors:  Hale Sakallı; Oznur Kal
Journal:  Clin Rheumatol       Date:  2013-04-17       Impact factor: 2.980

2.  Mean platelet volume: a controversial marker of disease activity in Crohn's disease.

Authors:  Song Liu; Jianan Ren; Gang Han; Gefei Wang; Guosheng Gu; Qiuyuan Xia; Jieshou Li
Journal:  Eur J Med Res       Date:  2012-10-12       Impact factor: 2.175

3.  Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients.

Authors:  Yuksel Dogan; Aliye Soylu; Gulay A Eren; Sule Poturoglu; Can Dolapcioglu; Kenan Sonmez; Habibe Duman; Isa Sevindir
Journal:  Int J Med Sci       Date:  2011-09-16       Impact factor: 3.738

4.  Mean platelet volume can indicate dietary adherence and disease severity of celiac disease.

Authors:  Emre Gerceker; Ahmed Ramiz Baykan; Serkan Cerrah; Hakan Yuceyar
Journal:  North Clin Istanb       Date:  2022-02-11

5.  Can mean platelet volume serve as a marker for prostatitis?

Authors:  Hatice Karaman; Cigdem Karakukcu; Derya Kocer
Journal:  Int J Med Sci       Date:  2013-08-21       Impact factor: 3.738

Review 6.  Biomarkers of inflammatory bowel disease.

Authors:  Yi Fengming; Wu Jianbing
Journal:  Dis Markers       Date:  2014-05-19       Impact factor: 3.434

7.  Mean Platelet Volume: A Reliable Marker of Inflammation in Recurrent Apthous Stomatitis and Behçet Disease?

Authors:  Engin Şenel; Bilal Acar; Emre Demir
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

Review 8.  Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment.

Authors:  Mohsen Norouzinia; Vahid Chaleshi; Amir Houshang Mohammad Alizadeh; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.